Analytical testing, QC

SGS invests €3.5m in its French bioanalytical site

13-Dec-2018 By Maggie Lynch

This second phase of the two-phase expansion project will increase the company’s bioanalytical capabilities at the site by 50% when the expansion is complete in 2020.

Biorasi closes PE deal, next stage to be ‘vastly different’ as CRO plans scale-up

13-Dec-2018 By Melissa Fassbender

Biorasi plans to scale several aspects of its global CRO business following a PE investment – and while it does not plan to “buy size,” smaller strategic acquisitions are not out of the question, says company executive.

Smithers Avanza: New lab to support all phases of biotherapeutics development

13-Dec-2018 By Melissa Fassbender

Smithers Avanza’s Bioanalytical Services division is adding 18,500 square feet of laboratory space in New Jersey to support the development of biotherapeutics.

Cambrex continues build-out at former PharmaCore site with $1m investment

11-Dec-2018 By Melissa Fassbender

Cambrex is investing $1m at its High Point, NC-based site, marking the most recent in a series of investments which will see the addition of 1,300 square feet and 15 new employees.

Trianni licenses humanized model platform to MacroGenics for oncology research

10-Dec-2018 By Maggie Lynch

Trianni to provide MacroGenics with humanized mouse model platform for its mAb therapeutics research.

PPD adds biologics testing to GMP lineup in Ireland

06-Dec-2018 By Melissa Fassbender

PPD is adding nearly 6,000 square feet of new lab space – and about 20 employees – dedicated to gene and cell therapy analytical testing at its site in Athlone, Ireland.

People on the Move: Outsourcing-Pharma roundup November ‘18

30-Nov-2018 By Melissa Fassbender

ABL named a successor to its previous CEO, Syneos has two new hires, and BTS Research appointed a VP to push its growth model. These, among other people on the move this month.

CRO sponsoring coworking lab in Boston as area continues to see strong demand for space

29-Nov-2018 By Melissa Fassbender

The CRO Calvert Laboratories is sponsoring a Boston-based coworking launchpad and will provide various services to the lab’s tenants.

Fusion Antibodies collab using AI to generate humanized antibodies

27-Nov-2018 By Maggie Lynch

Fusion Antibodies signed an agreement with Analytics Engines to bring machine learning and AI to its humanization platform in an aim to bolster product quality and manufacturability.

Exclusive interview

QPS expands Ph I capabilities to meet shifting demand, customer base

27-Nov-2018 By Melissa Fassbender

QPS has expanded its Phase I clinical trial capabilities by more than 20% and doubled its lab space, which will allow the CRO to accommodate ‘exponentially more sponsors’ as demand continues to increase.

New AI tech reduces research bottlenecks

21-Nov-2018 By Maggie Lynch

The new technology, Pattern to Knowledge (P2K), reduces “bottlenecks” in drug research by examining bio-sequences in a shorter time frame.

Once significantly behind, China begins to close the drug development gap

20-Nov-2018 By Melissa Fassbender

Moving forward, China will take a more integral role in global drug development, following several regulatory changes designed to accelerate innovation.

Building a 'better' CRO as sponsors drive industry consolidation

20-Nov-2018 By Melissa Fassbender

As sponsors drive CROs to consolidate, building a firm the size of Iqvia would take more than 20 years organically, says consultant – who shares the stuff of nightmares (and dreams).

PE firm brings CROs together, putting assay development and testing under one roof

20-Nov-2018 By Maggie Lynch

The PE firm Ampersand Capital Partners has acquired Pacific Biomarkers and is merging the CRO with Neomed-Labs to streamline clinical immunology development.

AAPS PharmSci 360

AI and computational psychiatry: Finding ‘hidden cues’

16-Nov-2018 By Maggie Lynch

The pharmaceutical industry has increasingly been adopting artificial intelligence – which has demonstrated the ability to predict instances of schizophrenia with 74% accuracy.